Beyond the brain: widespread pathology in Huntington's disease

被引:258
|
作者
van der Burg, Jorien M. M. [1 ]
Bjorkqvist, Maria [1 ]
Brundin, Patrik [1 ]
机构
[1] Lund Univ, Neuronal Survival Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden
来源
LANCET NEUROLOGY | 2009年 / 8卷 / 08期
基金
瑞典研究理事会;
关键词
TRANSGENIC MOUSE MODEL; CHOLESTEROL-BIOSYNTHESIS PATHWAY; PITUITARY-ADRENAL AXIS; PERIPHERAL-BLOOD CELLS; EXPANDED CAG REPEAT; R6/2; MOUSE; GENE-EXPRESSION; WEIGHT-LOSS; INCREASED APOPTOSIS; DIABETES-MELLITUS;
D O I
10.1016/S1474-4422(09)70178-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a polyglutamine stretch in the huntingtin protein. Today, more than 15 years after the genetic defect underlying HD was discovered, the pathogenesis is still not well understood and there is no adequate treatment. Research into this disorder has conventionally focused on neurological symptoms and brain pathology, particularly neurodegeneration in the basal ganglia and cerebral cortex. Mutant huntingtin is, however, ubiquitously expressed throughout the body. Indeed, contrary to earlier thinking, HD is associated with abnormalities in peripheral tissues. These abnormal changes are not all secondary to brain dysfunction, but most seem to be directly caused by expression of mutant huntingtin in peripheral tissues. In this article, we highlight this emerging field of research and how it might affect our understanding of the pathogenesis of this disease, the development of novel biomarkers of disease progression, and the identification of new potential treatments.
引用
收藏
页码:765 / 774
页数:10
相关论文
共 50 条
  • [41] Deep brain stimulation in Huntington's disease
    Bonelli, RM
    Gruber, A
    MOVEMENT DISORDERS, 2002, 17 (02) : 429 - 430
  • [42] Is brain lactate increased in Huntington's disease?
    Martin, W. R. Wayne
    Wieler, Marguerite
    Hanstock, Christopher C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 263 (1-2) : 70 - 74
  • [43] TAU pathology contributes to specific patterns of structural brain damage and neuropsychological heterogeneity in Huntington's disease
    Martinez-Horta, S.
    Perez-Perez, J.
    Perez-Gonzalez, R.
    Horta-Barba, A.
    Sampedro, F.
    Rivas-Asensio, E.
    Xucla, T.
    Guasch, M.
    Campolongo, A.
    Izquierdo-Barrionuevo, C.
    Pagonabarraga, J.
    Kulisevsky, J.
    MOVEMENT DISORDERS, 2020, 35 : S100 - S100
  • [44] Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology
    Maheshwari, Megha
    Shekhar, Shashi
    Singh, Brijesh Kumar
    Jamal, Imran
    Vatsa, Naman
    Kumar, Vipendra
    Sharma, Ankit
    Jana, Nihar Ranjan
    HUMAN MOLECULAR GENETICS, 2014, 23 (23) : 6235 - 6245
  • [45] CURCUMIN: A NATURAL COMPOUND TO COUNTERACT THE PATHOLOGY OF HUNTINGTON'S DISEASE?
    Elifani, Francesca
    Crispi, Stefania
    Filosa, Stefania
    Castaldo, Salvatore
    Capocci, Luca
    Madonna, Michele
    Amico, Enrico
    Pompeo, Giovanni
    Pompeo, Francesco
    Brunetti, Alexandra
    Ruggieri, Stefano
    Maglione, Vittorio
    Di Pardo, Alba
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A93 - A93
  • [46] Molecular imaging Markers to Track Huntington's Disease Pathology
    Wilson, Heather
    De Micco, Rosa
    Niccolini, Flavia
    Politis, Marios
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [47] Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain
    Fukuoka, Masashi
    Takahashi, Masaki
    Fujita, Hiromi
    Chiyo, Tomoko
    Popiel, H. Akiko
    Watanabe, Shoko
    Furuya, Hirokazu
    Murata, Miho
    Wada, Keiji
    Okada, Takashi
    Nagai, Yoshitaka
    Hohjoh, Hirohiko
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 11 : 79 - 90
  • [48] Huntington's disease: from pathology and genetics to potential therapies
    Imarisio, Sara
    Carmichael, Jenny
    Korolchuk, Viktor
    Chen, Chien-Wen
    Saiki, Shinji
    Rose, Claudia
    Krishna, Gauri
    Davies, Janet E.
    Ttofi, Evangelia
    Underwood, Benjamin R.
    Rubinsztein, David C.
    BIOCHEMICAL JOURNAL, 2008, 412 : 191 - 209
  • [49] Oligodendrocyte pathology in Huntington's disease: from mechanisms to therapeutics
    Bardile, Costanza Ferrari
    Radulescu, Carola I.
    Pouladi, Mahmoud A.
    TRENDS IN MOLECULAR MEDICINE, 2023, 29 (10) : 802 - 816
  • [50] UNDERSTANDING COGNITIVE HETEROGENEITY BEYOND DISEASE BURDEN IN HUNTINGTON'S DISEASE
    White, Alice
    Li, Yiming
    Kuan, Wei-Li
    Mason, Sarah
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A50 - A51